Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria

NCT02411994 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

197

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Pyronaridine-artesunate
DRUG: Artemether-lumefantrine combination

Sponsor

Royal Tropical Institute